Subscribe
shutterstock_1231106194_pajor_pawel
Pajor Pawel / Shutterstock.com
5 January 2023EuropeStaff Writer

Oxford University startup ordered to pay royalties

‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.

More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB